A small subset of vulnerable DNA sites can make cancer cells highly sensitive to targeted drugs called PARP inhibitors, a new study shows. Led by researchers at NYU Langone Health and its Perlmutter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results